157 related articles for article (PubMed ID: 30160020)
1. Increased levels of serum miR-148a-3p are associated with prostate cancer.
Dybos SA; Flatberg A; Halgunset J; Viset T; Rolfseng T; Kvam S; Skogseth H
APMIS; 2018 Sep; 126(9):722-731. PubMed ID: 30160020
[TBL] [Abstract][Full Text] [Related]
2. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
Song C; Chen H; Wang T; Zhang W; Ru G; Lang J
Prostate; 2015 Apr; 75(5):500-16. PubMed ID: 25597612
[TBL] [Abstract][Full Text] [Related]
3. Biomarker Potential of Plasma MicroRNA-150-5p in Prostate Cancer.
Paunescu IA; Bardan R; Marcu A; Nitusca D; Dema A; Negru S; Balacescu O; Balacescu L; Cumpanas A; Sirbu IO; Petrut B; Seclaman E; Marian C
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31484346
[No Abstract] [Full Text] [Related]
4. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
Daniel R; Wu Q; Williams V; Clark G; Guruli G; Zehner Z
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621736
[TBL] [Abstract][Full Text] [Related]
5. Plasma microRNA signature is associated with risk stratification in prostate cancer patients.
Al-Qatati A; Akrong C; Stevic I; Pantel K; Awe J; Saranchuk J; Drachenberg D; Mai S; Schwarzenbach H
Int J Cancer; 2017 Sep; 141(6):1231-1239. PubMed ID: 28571116
[TBL] [Abstract][Full Text] [Related]
6. Correlations between serum levels of microRNA-148a-3p and microRNA-485-5p and the progression and recurrence of prostate cancer.
He W; Zhang F; Jiang F; Liu H; Wang G
BMC Urol; 2022 Nov; 22(1):195. PubMed ID: 36434610
[TBL] [Abstract][Full Text] [Related]
7. Combination of three miRNA (miR-141, miR-21, and miR-375) as potential diagnostic tool for prostate cancer recognition.
Porzycki P; Ciszkowicz E; Semik M; Tyrka M
Int Urol Nephrol; 2018 Sep; 50(9):1619-1626. PubMed ID: 30014459
[TBL] [Abstract][Full Text] [Related]
8. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
9. Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing.
Hart M; Nolte E; Wach S; Szczyrba J; Taubert H; Rau TT; Hartmann A; Grässer FA; Wullich B
Mol Cancer Res; 2014 Feb; 12(2):250-63. PubMed ID: 24337069
[TBL] [Abstract][Full Text] [Related]
10. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E
Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660
[TBL] [Abstract][Full Text] [Related]
11. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.
Guzel E; Karatas OF; Semercioz A; Ekici S; Aykan S; Yentur S; Creighton CJ; Ittmann M; Ozen M
Int J Cancer; 2015 Feb; 136(4):875-9. PubMed ID: 24976077
[TBL] [Abstract][Full Text] [Related]
12. Detection of miRNAs in urine of prostate cancer patients.
Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of miR-148a-3p and miR-106a-5p as Biomarkers for Prostate Cancer: Pilot Study.
Coman RA; Schitcu VH; Budisan L; Raduly L; Braicu C; Petrut B; Coman I; Berindan-Neagoe I; Al Hajjar N
Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790213
[TBL] [Abstract][Full Text] [Related]
14. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
16. High-Level Expression of microRNA-21 in Peripheral Blood Mononuclear Cells Is a Diagnostic and Prognostic Marker in Prostate Cancer.
Huang W; Kang XL; Cen S; Wang Y; Chen X
Genet Test Mol Biomarkers; 2015 Sep; 19(9):469-75. PubMed ID: 26247873
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA signature for the diagnosis of very high-risk prostate cancer.
Alhasan AH; Scott AW; Wu JJ; Feng G; Meeks JJ; Thaxton CS; Mirkin CA
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10655-60. PubMed ID: 27601638
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.
Baltruskeviciene E; Schveigert D; Stankevicius V; Mickys U; Zvirblis T; Bublevic J; Suziedelis K; Aleknavicius E
BMC Cancer; 2017 Sep; 17(1):607. PubMed ID: 28863773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]